Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Replication study for associations between polymorphisms in the CLDN5 and DGCR2 genes in the 22q11 deletion syndrome region and schizophrenia.

Ishiguro H, Imai K, Koga M, Horiuchi Y, Inada T, Iwata N, Ozaki N, Ujike H, Itokawa M, Kunugi H, Sasaki T, Watanabe Y, Someya T, Arinami T.

Psychiatr Genet. 2008 Oct;18(5):255-6. doi: 10.1097/YPG.0b013e328306c7dc. No abstract available.

PMID:
18797402
2.

ZDHHC8 single nucleotide polymorphism rs175174 is not associated with psychiatric features of the 22q11 deletion syndrome or schizophrenia.

Demily C, Legallic S, Bou J, Houy-Durand E, Van Amelsvoort T, Zinkstok J, Manouvrier-Hanue S, Vogels A, Drouin-Garraud V, Philip N, Philippe A, Héron D, Sarda P, Petit M, Thibaut F, Frébourg T, Campion D.

Psychiatr Genet. 2007 Oct;17(5):311-2. No abstract available.

PMID:
17728672
3.

A complete genetic association scan of the 22q11 deletion region and functional evidence reveal an association between DGCR2 and schizophrenia.

Shifman S, Levit A, Chen ML, Chen CH, Bronstein M, Weizman A, Yakir B, Navon R, Darvasi A.

Hum Genet. 2006 Sep;120(2):160-70. Epub 2006 Jun 17.

PMID:
16783572
4.

Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.

Prasad SE, Howley S, Murphy KC.

Dev Disabil Res Rev. 2008;14(1):26-34. doi: 10.1002/ddrr.5. Review.

PMID:
18636634
5.

22q11 deletion syndrome in childhood onset schizophrenia: an update.

Sporn A, Addington A, Reiss AL, Dean M, Gogtay N, Potocnik U, Greenstein D, Hallmayer J, Gochman P, Lenane M, Baker N, Tossell J, Rapoport JL.

Mol Psychiatry. 2004 Mar;9(3):225-6. No abstract available.

PMID:
14699434
6.

[Schizophrenia and the 22q11 deletion syndrome].

Verhoeven WM, Tuinier S.

Ned Tijdschr Geneeskd. 2003 Feb 15;147(7):317-8; author reply 318. Dutch. No abstract available.

PMID:
12622010
7.

Atypical deletion of 22q11.2: detection using the FISH TBX1 probe and molecular characterization with high-density SNP arrays.

Beaujard MP, Chantot S, Dubois M, Keren B, Carpentier W, Mabboux P, Whalen S, Vodovar M, Siffroi JP, Portnoï MF.

Eur J Med Genet. 2009 Sep-Oct;52(5):321-7. doi: 10.1016/j.ejmg.2009.05.010. Epub 2009 May 23.

PMID:
19467348
8.

A study of the combined effect of the CLDN5 locus and the genes for the phospholipid metabolism pathway in schizophrenia.

Wei J, Hemmings GP.

Prostaglandins Leukot Essent Fatty Acids. 2005 Dec;73(6):441-5. Epub 2005 Sep 21.

PMID:
16181776
9.

Performance on the Modified Card Sorting Test and its relation to psychopathology in adolescents and young adults with 22q11.2 deletion syndrome.

Rockers K, Ousley O, Sutton T, Schoenberg E, Coleman K, Walker E, Cubells JF.

J Intellect Disabil Res. 2009 Jul;53(7):665-76. doi: 10.1111/j.1365-2788.2009.01178.x. Epub 2009 May 12.

PMID:
19460069
10.

[Cerebral polymicrogyria and 22q11 deletion syndrome].

Arriola-Pereda G, Verdú-Pérez A, de Castro-De Castro P.

Rev Neurol. 2009 Feb 16-28;48(4):188-90. Spanish.

11.

DiGeorge anomaly in the absence of chromosome 22q11.2 deletion.

Rope AF, Cragun DL, Saal HM, Hopkin RJ.

J Pediatr. 2009 Oct;155(4):560-5. doi: 10.1016/j.jpeds.2009.04.010.

PMID:
19595366
12.

The C/At is out of the bag: a gene for mental illness.

Wong ML.

Pharmacogenomics J. 2001;1(1):13-4. No abstract available.

PMID:
11913720
13.

Schizophrenia susceptibility genes on chromosome 13q32.

Hu Y, Xu Q, Ju GZ, Liu SZ, Shi JP, Yu YQ, Wei J.

Chin Med J (Engl). 2004 Mar;117(3):464-6. No abstract available.

PMID:
15043795
14.

Association of MCTP2 gene variants with schizophrenia in three independent samples of Scandinavian origin (SCOPE).

Djurovic S, Le Hellard S, Kähler AK, Jönsson EG, Agartz I, Steen VM, Hall H, Wang AG, Rasmussen HB, Melle I, Werge T, Andreassen OA.

Psychiatry Res. 2009 Aug 15;168(3):256-8. doi: 10.1016/j.psychres.2008.08.007. Epub 2009 Feb 15.

PMID:
19223264
15.

DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study.

Jönsson EG, Saetre P, Vares M, Andreou D, Larsson K, Timm S, Rasmussen HB, Djurovic S, Melle I, Andreassen OA, Agartz I, Werge T, Hall H, Terenius L.

Neuropsychobiology. 2009;59(3):142-50. doi: 10.1159/000218076. Epub 2009 May 12.

PMID:
19439994
16.

Introduction: advances in research on velo-cardio-facial syndrome/22q11.2 deletion syndrome.

Kates WR, Emanuel BS.

Dev Disabil Res Rev. 2008;14(1):1-2. doi: 10.1002/ddrr.1. No abstract available.

PMID:
18636630
17.

Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis.

Beuten J, Garcia D, Brand TC, He X, Balic I, Canby-Hagino E, Troyer DA, Baillargeon J, Hernandez J, Thompson IM, Leach RJ, Naylor SL.

J Urol. 2009 Oct;182(4):1614-20. doi: 10.1016/j.juro.2009.06.016. Epub 2009 Aug 15.

PMID:
19683737
18.

Exome sequencing supports a de novo mutational paradigm for schizophrenia.

Xu B, Roos JL, Dexheimer P, Boone B, Plummer B, Levy S, Gogos JA, Karayiorgou M.

Nat Genet. 2011 Aug 7;43(9):864-8. doi: 10.1038/ng.902.

19.

Two distinctive classic genetic syndromes, 22q11.2 deletion syndrome and Angelman syndrome, occurring within the same family.

Kosaki R, Migita O, Takahashi T, Kosaki K.

Am J Med Genet A. 2009 Feb 15;149A(4):702-5. doi: 10.1002/ajmg.a.32666.

PMID:
19288551
20.

Dysbindin and d-amino-acid-oxidase gene polymorphisms associated with positive and negative symptoms in schizophrenia.

Wirgenes KV, Djurovic S, Agartz I, Jonsson EG, Werge T, Melle I, Andreassen OA.

Neuropsychobiology. 2009;60(1):31-6. doi: 10.1159/000235799. Epub 2009 Sep 1.

PMID:
19729970

Supplemental Content

Support Center